Methyl Aminolevulinate is a photosensitizing prodrug utilized in photodynamic therapy for the treatment of actinic keratosis and field cancerization. As a topical agent, it is metabolized within target… Read more








Methyl Aminolevulinate is a photosensitizing prodrug utilized in photodynamic therapy for the treatment of actinic keratosis and field cancerization. As a topical agent, it is metabolized within target cells into protoporphyrin IX, which induces selective phototoxicity upon light exposure. This category features the active pharmaceutical ingredient alongside a comprehensive selection of reference standards, including pharmacopeial and non-pharmacopeial impurities. These compounds are essential for impurity profiling, allowing analytical chemists to identify, monitor, and quantify degradation products during stability testing and quality control procedures. The inclusion of stable isotope-labelled standards facilitates precise quantification and accurate method validation in complex matrices, supporting rigorous pharmacokinetic studies and regulatory compliance. Pharmaceutical laboratories rely on these high-quality reference materials to ensure the purity, safety, and efficacy of drug formulations throughout the development lifecycle and routine batch analysis.